Ketorolac
- Oral / IMKetorolacStronger but more likely to cause renal failure / peptic ulceration
- Mechanism of Action
- Inhibits cyclooxygenase, the enzyme responsible for production of thromboxanes, prostacyclin and prostaglandins from arachidonic acid.
- Pharmacology
- Competitively and non-selectively binds to COX.
Clinical Use
- Indications
- Adverse Effects